{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:02Z","timestamp":1786986842687,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016026","name":"RRF Foundation for Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002286"],"award-info":[{"award-number":["BX002286"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41 AI147697"],"award-info":[{"award-number":["R41 AI147697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI167155"],"award-info":[{"award-number":["R01 AI167155"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clim.2023.109635","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T21:47:10Z","timestamp":1683323230000},"page":"109635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models"],"prefix":"10.1016","volume":"251","author":[{"given":"Osama","family":"Alzoubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya Pulido","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel C.","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Zomorrodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Shahrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5877","key":"10.1016\/j.clim.2023.109635_bb0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1154370","article-title":"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome","volume":"320","author":"Lin","year":"2008","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.str.2012.02.010","article-title":"Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R","volume":"20","author":"Ma","year":"2012","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.str.2013.01.018","article-title":"Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor","volume":"21","author":"Felix","year":"2013","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00774-013-0476-3","article-title":"IL-34 and CSF-1: similarities and differences","volume":"31","author":"Nakamichi","year":"2013","journal-title":"J. Bone Miner. Metab."},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/JLB.MR1117-457R","article-title":"Interleukin-34, a comprehensive review","volume":"104","author":"Baghdadi","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"8","key":"10.1016\/j.clim.2023.109635_bb0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ni.2360","article-title":"IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia","volume":"13","author":"Wang","year":"2012","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.immuni.2012.11.001","article-title":"Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia","volume":"37","author":"Greter","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.clim.2023.109635_bb0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.1209822","article-title":"Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells","volume":"88","author":"Wei","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.clim.2023.109635_bb0050","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.41792","article-title":"Interleukin-34 reprograms glycolytic and Osteoclastic rheumatoid arthritis macrophages via Syndecan 1 and macrophage colony-stimulating factor receptor","volume":"73","author":"Van Raemdonck","year":"2021","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clim.2023.109635_bb0055","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1189\/jlb.0308171","article-title":"CSF-1 receptor structure\/function in MacCsf1r\u2212\/\u2212 macrophages: regulation of proliferation, differentiation, and morphology","volume":"84","author":"Yu","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.clim.2023.109635_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013587","article-title":"Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells","volume":"5","author":"Knowlton","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.clim.2023.109635_bb0065","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","article-title":"The M-CSF receptor in osteoclasts and beyond","volume":"52","author":"Mun","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0070","article-title":"Differential effects of CSF-1R D802V and KIT D816V homologous mutations on receptor tertiary structure and allosteric communication","volume":"9","author":"Gomes","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41598-017-18433-4","article-title":"IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential","volume":"8","author":"Boulakirba","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109635_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cyto.2017.08.020","article-title":"Interleukin 34, from pathogenesis to clinical applications","volume":"99","author":"Baghdadi","year":"2017","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.clim.2023.109635_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/mcbr.1999.0123","article-title":"Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation","volume":"1","author":"Marks","year":"1999","journal-title":"Mol. Cell Biol. Res. Commun."},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0090","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/j.1460-2075.1992.tb05181.x","article-title":"Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3\u2032-kinase SH2 domains: a model for SH2-mediated receptor-target interactions","volume":"11","author":"Reedijk","year":"1992","journal-title":"EMBO J."},{"issue":"31","key":"10.1016\/j.clim.2023.109635_bb0095","doi-asserted-by":"crossref","first-page":"18350","DOI":"10.1074\/jbc.271.31.18350","article-title":"Formation of STAT5-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor","volume":"271","author":"Novak","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0100","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.7150\/thno.50683","article-title":"The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis","volume":"11","author":"Munoz-Garcia","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.clim.2023.109635_bb0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cyto.2015.05.029","article-title":"IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization","volume":"76","author":"Segaliny","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2023.109635_bb0110","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fimmu.2019.02019","article-title":"Function of CSF1 and IL34 in macrophage homeostasis, inflammation, and cancer","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Immunol."},{"issue":"30","key":"10.1016\/j.clim.2023.109635_bb0115","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1074\/jbc.M112.442731","article-title":"Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34","volume":"288","author":"Nandi","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0120","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbamcr.2015.01.023","article-title":"Syndecan-1 regulates the biological activities of interleukin-34","volume":"1853","author":"Segaliny","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2009.01.025","article-title":"A novel role for receptor like protein tyrosine phosphatase zeta in modulation of sensorimotor responses to noxious stimuli: evidences from knockout mice studies","volume":"201","author":"Lafont","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-5793(94)01093-5","article-title":"Multiple receptor-like protein tyrosine phosphatases in the form of chondroitin sulfate proteoglycan","volume":"354","author":"Maeda","year":"1994","journal-title":"FEBS Lett."},{"issue":"43","key":"10.1016\/j.clim.2023.109635_bb0135","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.1074\/jbc.M111.270140","article-title":"Consensus substrate sequence for protein-tyrosine phosphatase receptor type Z","volume":"286","author":"Fujikawa","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.clim.2023.109635_bb0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ydbio.2012.03.026","article-title":"The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation","volume":"367","author":"Nandi","year":"2012","journal-title":"Dev. Biol."},{"issue":"8","key":"10.1016\/j.clim.2023.109635_bb0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41374-022-00772-0","article-title":"IL-34 and protein-tyrosine phosphatase receptor type-zeta-dependent mechanisms limit arthritis in mice","volume":"102","author":"Gonzalez-Sanchez","year":"2022","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2005.11.006","article-title":"Colony-stimulating factor-1 in immunity and inflammation","volume":"18","author":"Chitu","year":"2006","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2023.109635_bb0155","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190290","article-title":"Emerging roles of IL-34 in health and disease","volume":"217","author":"Lelios","year":"2020","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.clim.2023.109635_bb0160","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1753425917725391","article-title":"1alpha,25-Dihydroxyvitamin D3 up-regulates IL-34 expression in SH-SY5Y neural cells","volume":"23","author":"Zhang","year":"2017","journal-title":"Innate Immun."},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0165","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/humrep\/dey037","article-title":"Interleukin-34 is present at the fetal-maternal interface and induces immunoregulatory macrophages of a decidual phenotype in vitro","volume":"33","author":"Lindau","year":"2018","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0170","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/eji.201344365","article-title":"Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells","volume":"44","author":"Wang","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2023.109635_bb0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12915-015-0121-9","article-title":"The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor","volume":"13","author":"Garceau","year":"2015","journal-title":"BMC Biol."},{"issue":"3","key":"10.1016\/j.clim.2023.109635_bb0180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/eji.201545917","article-title":"Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00296-014-3056-5","article-title":"Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis","volume":"35","author":"Chang","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.clim.2023.109635_bb0190","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3899\/jrheum.130356","article-title":"Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis","volume":"40","author":"Moon","year":"2013","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/annrheumdis-2011-200096","article-title":"Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients","volume":"71","author":"Chemel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.clim.2023.109635_bb0200","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/jir.2012.0122","article-title":"Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production","volume":"33","author":"Tian","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"issue":"14","key":"10.1016\/j.clim.2023.109635_bb0205","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00018-017-2482-4","article-title":"Immunoregulatory properties of the cytokine IL-34","volume":"74","author":"Guillonneau","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.clim.2023.109635_bb0210","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00296-010-1688-7","article-title":"Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 mRNA via JNK- and p44\/42 MAPK-NF-kappaB pathway but not p38 pathway in osteoblasts","volume":"31","author":"Eda","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0215","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/kes435","article-title":"IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren\u2019s syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes","volume":"52","author":"Ciccia","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.clim.2023.109635_bb0220","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/1756-185X.13773","article-title":"Serum levels of interleukin-34 and clinical correlation in patients with primary Sjogren's syndrome","volume":"23","author":"Liu","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22010035","article-title":"Serum Interleukin-34 levels are elevated in patients with systemic lupus erythematosus","volume":"22","author":"Wang","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0230","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1038\/s41598-018-21859-z","article-title":"Elevated serum Interleukin-34 level in patients with systemic lupus erythematosus is associated with disease activity","volume":"8","author":"Xie","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0235","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.clim.2023.109635_bb0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2018090901","article-title":"IL-34-dependent Intrarenal and systemic mechanisms promote lupus nephritis in MRL-Fas(lpr) mice","volume":"30","author":"Wada","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.clim.2023.109635_bb0245","doi-asserted-by":"crossref","first-page":"E1263","DOI":"10.1210\/jc.2013-4409","article-title":"IL-34 is associated with obesity, chronic inflammation, and insulin resistance","volume":"99","author":"Chang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.clim.2023.109635_bb0250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/1354750X.2016.1138321","article-title":"The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications","volume":"21","author":"Zorena","year":"2016","journal-title":"Biomarkers"},{"issue":"8","key":"10.1016\/j.clim.2023.109635_bb0255","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00125-011-2188-3","article-title":"Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals","volume":"54","author":"Below","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0260","first-page":"1","article-title":"Interleukin-34 induces monocytic-like differentiation in leukemia cell lines","volume":"6","author":"Booker","year":"2015","journal-title":"Int J Biochem Mol Biol"},{"issue":"8","key":"10.1016\/j.clim.2023.109635_bb0265","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1172\/JCI81166","article-title":"IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease","volume":"125","author":"Baek","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245340","article-title":"Reno-protective effect of IL-34 inhibition on cisplatin-induced nephrotoxicity in mice","volume":"16","author":"Wada","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-020-00350-7","article-title":"Macrophages produce and functionally respond to interleukin-34 in colon cancer","volume":"6","author":"Franze","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0280","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/TP.0000000000002194","article-title":"IL-34 inhibits acute rejection of rat liver transplantation by inducing Kupffer cell M2 polarization","volume":"102","author":"Zhao","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2023.109635_bb0285","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3389\/fimmu.2020.01496","article-title":"IL-34 actions on FOXP3(+) Tregs and CD14(+) monocytes control human graft rejection","volume":"11","author":"Bezie","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2023.109635_bb0290","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41423-022-00886-x","article-title":"Dysregulation of IL-34 ligation to SDC-1 mitigates collagen-induced arthritis","volume":"19","author":"Meyer","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0295","doi-asserted-by":"crossref","first-page":"22239","DOI":"10.1038\/s41598-020-79312-z","article-title":"Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0300","doi-asserted-by":"crossref","first-page":"16378","DOI":"10.1038\/s41598-021-95839-1","article-title":"IL-34 affects fibroblast-like synoviocyte proliferation, apoptosis and function by regulating IL-17","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109635_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1567120","article-title":"IL-34 upregulated Th17 production through increased IL-6 expression by rheumatoid fibroblast-like Synoviocytes","volume":"2017","author":"Wang","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10067-017-3746-y","article-title":"Increased IL-6 expression on THP-1 by IL-34 stimulation up-regulated rheumatoid arthritis Th17 cells","volume":"37","author":"Wang","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0315","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/eji.201444606","article-title":"IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1alpha","volume":"45","author":"Foucher","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2023.109635_bb0320","first-page":"10","article-title":"Interleukin-34 aggravates the severity of arthritis in collagen-induced arthritis mice by inducing Interleukin-17 production","volume":"2017","author":"Zhang","year":"2018","journal-title":"J. Interf. Cytokine Res."},{"issue":"10","key":"10.1016\/j.clim.2023.109635_bb0325","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1172\/JCI81227","article-title":"IL-34 is a Treg-specific cytokine and mediates transplant tolerance","volume":"125","author":"Bezie","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.clim.2023.109635_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.988","article-title":"IL-34 deficiency impairs FOXP3(+) Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis","volume":"12","author":"Freuchet","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.clim.2023.109635_bb0335","article-title":"Il-34 regulates MAPKs, PI3K\/Akt, JAK and NF-kappa B pathways and induces the expression of inflammatory factors in RA-FLS","author":"Yang","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.clim.2023.109635_bb0340","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3390\/cancers12123537","article-title":"Interleukin-34 enhances the tumor promoting function of colorectal cancer-associated fibroblasts","volume":"12","author":"Franze","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0345","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar3693","article-title":"Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis","volume":"14","author":"Hwang","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.29376","article-title":"Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment","volume":"137","author":"Segaliny","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"6937","key":"10.1016\/j.clim.2023.109635_bb0355","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.clim.2023.109635_bb0360","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00018-018-2817-9","article-title":"Mechanisms involved in normal and pathological osteoclastogenesis","volume":"75","author":"Park-Min","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.clim.2023.109635_bb0365","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.clim.2023.109635_bb0370","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0375","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00281-019-00757-0","article-title":"Metabolic reprogramming in osteoclasts","volume":"41","author":"Park-Min","year":"2019","journal-title":"Semin. Immunopathol."},{"issue":"7","key":"10.1016\/j.clim.2023.109635_bb0380","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0385","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0390","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jbspin.2013.04.014","article-title":"Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38","volume":"80","author":"Clavel","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.clim.2023.109635_bb0395","first-page":"7809","article-title":"Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.2684","article-title":"Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis","volume":"221","author":"Baud'huin","year":"2010","journal-title":"J. Pathol."},{"issue":"25","key":"10.1016\/j.clim.2023.109635_bb0405","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1073\/pnas.1207361109","article-title":"Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op\/op mice","volume":"109","author":"Nakamichi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.clim.2023.109635_bb0410","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V99.1.111","article-title":"Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects","volume":"99","author":"Dai","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2023.109635_bb0415","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cbin.10771","article-title":"AG490 suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages","volume":"41","author":"Cheng","year":"2017","journal-title":"Cell Biol. Int."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:13Z","timestamp":1778616193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":83,"alternative-id":["S1521661623001341"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109635","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109635"}}